A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story... (Q42164486)

17 October 2017

A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story... (English)

1 reference

17 October 2017

0 references

M Dalle Carbonare

1

1 reference

17 October 2017

E Del Giudice

2

1 reference

17 October 2017

A Stecca

3

1 reference

17 October 2017

D Colavito

4

1 reference

17 October 2017

M Fabris

5

1 reference

17 October 2017

A D'Arrigo

6

1 reference

17 October 2017

D Bernardini

7

1 reference

17 October 2017

M Dam

8

1 reference

17 October 2017

A Leon

9

1 reference

17 October 2017

1 May 2008

1 reference

Journal of Neuroendocrinology

17 October 2017

1 reference

17 October 2017

20 Suppl 1

1 reference

17 October 2017

26-34

1 reference

Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution

17 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Attenuation of allergic contact dermatitis through the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

The endogenous cannabinoid system protects against colonic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

The orphan receptor GPR55 is a novel cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Biochemistry and pharmacology of endovanilloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

The capsaicin receptor: a heat-activated ion channel in the pain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Characterization of the human HCN1 channel and its inhibition by capsazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

The transient receptor potential vanilloid 1: role in airway inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

An anorexic lipid mediator regulated by feeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01689.X

10.1111/J.1365-2826.2008.01689.X

21 January 2018

Identifiers

DOI

1 reference

17 October 2017

1 reference